Results 91 to 100 of about 1,441,839 (169)
Prenatal Screening Technologies and Test Issues
Maternal serum screening began with the measurement of serum alpha fetal protein to detect open neural tube defects, which led to the implementation of routine serum-based prenatal screening in the second trimester for Down syndrome.
Patricia L. Devers Winters +2 more
core +1 more source
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund +5 more
wiley +1 more source
Economic evaluation of cystic fibrosis screening: A Review of the literature, CHERE Working Paper 2006/6 [PDF]
Objectives: To critically examine the economic evidence on Cystic Fibrosis (CF) screening and to understand issues relating to the transferability of findings to the Australian context for policy decisions.
Muralikrishnan Radhakrishnan +4 more
core
Noninvasive prenatal testing for aneuploidy – ready for prime time? [PDF]
Noninvasive prenatal diagnosis using cell-free fetal DNA in the maternal plasma is moving into routine clinical practice for some indications. Here we discuss exciting developments in noninvasive prenatal diagnosis for aneuploidy afforded by recent ...
Wright, David +8 more
core +1 more source
Prenatal Diagnosis and Screening for Down Syndrome [PDF]
This book provides a concise yet comprehensive source of current information on Down syndrome. Research workers, scientists, medical graduates and paediatricians will find it an excellent source for reference and review.
core +1 more source
Special Report: Prenatal Screening Policies in Europe 2010
Since the setting up of EUROCAT in 1980 there has been a continuous increase in the proportion of congenital malformations that are diagnosed prenatally. EUROCAT studies have shown significant regional differences in prenatal detection rates in Europe. A
Boyd, Patricia +5 more
core
Background: Genetic carrier screening and noninvasive prenatal testing (NIPT) have transformed prenatal care by enabling early detection of hereditary and chromosomal disorders.
Muhammad Adrianes Bachnas +19 more
doaj +1 more source
Indications for Invasive Prenatal Testing before and after Noninvasive Prenatal Screening
Objective To evaluate changes in indications for genetic testing after introduction of noninvasive prenatal screening (NIPS) into a single center. Pregnancy outcomes and results of testing were evaluated.
Lisa Gill, Tracy Prosen
core +1 more source
Pregnant women's and policymakers' preferences for the expansion of noninvasive prenatal screening: A discrete choice experiment approach study. [PDF]
Nguyen HM +5 more
europepmc +1 more source
A Situational Overview of Prenatal Screening Services in Bhutan
Prenatal genetic testing is to determine the possibility of the fetus having a genetic aberration or birth defect. Prenatal screening consists of serum analytes screening with or without nuchal translucency (NT) scanning or with cell‐free DNA (CfDNA ...
Yeshey Dorjey +7 more
doaj +1 more source

